UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Quetiapine: A review of its safety in the management of schizophrenia

Drug safety, 2000-10, Vol.23 (4), p.295-307

2000

Volltextzugriff (PDF)

A comparison of the effects of quetiapine (‘Seroquel’) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment

International clinical psychopharmacology, 2000-05, Vol.15 (3), p.121-131

2000

Volltextzugriff (PDF)

A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia

Acta psychiatrica Scandinavica, 2000-03, Vol.101 (3), p.218-225

2000

Volltextzugriff (PDF)

Zotepine in the prevention of recurrence : a randomised, double-blind, placebo-controlled study for chronic schizophrenia

Psychopharmacologia, 2000-06, Vol.150 (3), p.237-243

2000

Volltextzugriff (PDF)

A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia

Acta psychiatrica Scandinavica, 2000-03, Vol.101 (3), p.218-225

2000

Volltextzugriff (PDF)

The safety and efficacy of zotepine in the treatment of schizophrenia: Results of a one-year naturalistic clinical trial

International journal of psychiatry in clinical practice, 2000, Vol.4 (4), p.299-306

2000

Volltextzugriff (PDF)

Maintenance of long-term efficacy with ‘seroquel’

Schizophrenia research, 2000, Vol.41 (1), p.205-205

2000

Volltextzugriff (PDF)

A DOUBLE‐BLIND, COMPARATIVE STUDY OF DOTHIEPIN AND CLOMIPRAMINE IN THE TREATMENT OF MAJOR DEPRESSIVE ILLNESS

International journal of clinical practice (Esher), 1997-09, Vol.51 (6), p.360-363

1997

Volltextzugriff (PDF)

Efficacy of seroquel in treating all of the positive and negative symptoms of schizophrenia

Schizophrenia research, 2000, Vol.41 (1), p.203-203

2000

Volltextzugriff (PDF)

Weight changes in patients treated with seroquel (quetiapine)

Schizophrenia research, 2000, Vol.41 (1), p.206-206

2000

Volltextzugriff (PDF)

Efficacy and tolerability of ‘Seroquel’ compared with haloperidol in schizophrenic patients partially responsive to conventional antipsychotic treatment

European neuropsychopharmacology, 1999-09, Vol.9, p.267-267

1999

Volltextzugriff (PDF)

P.2.101 ‘Seroquel’ (quetiapine) in the treatment of schizophrenia — overview of efficacy data in 6 phase II/III clinical trials

European neuropsychopharmacology, 1997-09, Vol.7, p.S224-S224

1997

Volltextzugriff (PDF)

P.2.100 Extrapyrimidal symptom and tolerability profile of ‘Seroquel’™ (quetiapine): An overview of phase II/III placebo controlled trials

European neuropsychopharmacology, 1997-09, Vol.7, p.S224-S224

1997

Volltextzugriff (PDF)

Zotepine in the prevention of relapse

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.41S-41S

1997

Volltextzugriff (PDF)

Antigen-induced non-specific suppressor factor in sheep efferent lymph is prostaglandin E2

Immunology, 1981-05, Vol.43 (1), p.205-212

1981

Volltextzugriff (PDF)

Zotepine in acute exacerbation of schizophrenia: A comparison versus chlorpromazine and placebo

European neuropsychopharmacology, 1996-06, Vol.6, p.148-148

1996

Volltextzugriff (PDF)

A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group

International clinical psychopharmacology, 2000-05, Vol.15 (3), p.121-131

2000

Volltextzugriff (PDF)

A comparison of an atypical (zotepine) and classical (haloperidol) antipsychotic, in patients with acute exacerbation of schizophrenia

Schizophrenia research, 1996-02, Vol.18 (2), p.133-133

1996

Volltextzugriff (PDF)

A multicentre naturalistic long term study of zotepine

European psychiatry, 1997, Vol.12 (S2), p.214s-214s

1997

Volltextzugriff (PDF)

P-4-20 Double-blind study of zotepine vs haloperidol in schizophrenia

European neuropsychopharmacology, 1995-09, Vol.5 (3), p.333-333

1995

Volltextzugriff (PDF)

DOTHIEPIN IS SUPERIOR TO LORAZEPAM AND PLACEBO IN RELIEVING MENOPAUSAL ANXIETY AND DEPRESSION

Clinical neuropharmacology, 1992, Vol.15, p.339

1992

Volltextzugriff (PDF)

A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial

Psychopharmacology bulletin, 1996, Vol.32 (1), p.81

1996

Volltextzugriff (PDF)

Activation of the alternative complement pathway by normal and transformed cells in homologous and heterologous sera

European journal of immunology, 1981, Vol.11 (2), p.126-132

1981

Volltextzugriff (PDF)

Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum

European journal of immunology, 1981, Vol.11 (2), p.132-135

1981

Volltextzugriff (PDF)

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial

Thorax, 2022-05, Vol.77 (5), p.461

2022

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(9)
Adult
(6)
Female
(6)
Male
(6)
Antipsychotic Agents - Therapeutic Use
(5)
Double-Blind Method
(5)
Middle Aged
(5)
Pharmacology & Pharmacy
(5)
Psychiatry
(5)
Schizophrenia
(5)
Schizophrenia - Drug Therapy
(5)
Adolescent
(4)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Pharmacology. Drug Treatments
(4)
Zotepine
(4)
Aged
(3)
Dibenzothiepins - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quetiapine: A review of its safety in the management of schizophrenia

A comparison of the effects of quetiapine (‘Seroquel’) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment

A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia

Zotepine in the prevention of recurrence : a randomised, double-blind, placebo-controlled study for chronic schizophrenia

A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia

The safety and efficacy of zotepine in the treatment of schizophrenia: Results of a one-year naturalistic clinical trial

Maintenance of long-term efficacy with ‘seroquel’

A DOUBLE‐BLIND, COMPARATIVE STUDY OF DOTHIEPIN AND CLOMIPRAMINE IN THE TREATMENT OF MAJOR DEPRESSIVE ILLNESS

Efficacy of seroquel in treating all of the positive and negative symptoms of schizophrenia

Weight changes in patients treated with seroquel (quetiapine)

Efficacy and tolerability of ‘Seroquel’ compared with haloperidol in schizophrenic patients partially responsive to conventional antipsychotic treatment

P.2.101 ‘Seroquel’ (quetiapine) in the treatment of schizophrenia — overview of efficacy data in 6 phase II/III clinical trials

P.2.100 Extrapyrimidal symptom and tolerability profile of ‘Seroquel’™ (quetiapine): An overview of phase II/III placebo controlled trials

Zotepine in the prevention of relapse

Antigen-induced non-specific suppressor factor in sheep efferent lymph is prostaglandin E2

Zotepine in acute exacerbation of schizophrenia: A comparison versus chlorpromazine and placebo

A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group

A comparison of an atypical (zotepine) and classical (haloperidol) antipsychotic, in patients with acute exacerbation of schizophrenia

A multicentre naturalistic long term study of zotepine

P-4-20 Double-blind study of zotepine vs haloperidol in schizophrenia

DOTHIEPIN IS SUPERIOR TO LORAZEPAM AND PLACEBO IN RELIEVING MENOPAUSAL ANXIETY AND DEPRESSION

A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial

Activation of the alternative complement pathway by normal and transformed cells in homologous and heterologous sera

Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial

Suchergebnisse filtern